Tirzepatide Shows Benefit in Obstructive Sleep Apnea, SURMOUNT-OSA Trial
Topline data from the SURMOUNT-OSA studies provide insight into the effects of tirzepatide in OSA with obesity, with Lilly disclosing plans for a regulatory submission mid-year.